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Abstract.
Background:Mathematical models of the interactions between alphasynuclein (S) and reactive oxygen species (ROS) predict
a systematic and irreversible switching to damagingly high levels of ROS after sufficient exposure to risk factors associated with
Parkinson’s disease (PD).
Objectives: We tested this prediction by continuously monitoring real-time changes in neurochemical levels over periods of
several days in animals exposed to a toxin known to cause Parkinsonian symptoms.
Methods:Nitric oxide (NO) sensors were implanted in the brains of freely moving rats and the NO levels continuously recorded
while the animals were exposed to paraquat (PQ) injections of various amounts and frequencies.
Results: Long-term, real-time measurement of NO in a cohort of animals showed systematic switching in levels when PQ injec-
tions of sufficient size and frequency were administered. The experimental observations of changes in NO imply a corresponding
switching in endogenous ROS levels and support theoretical predictions of an irreversible change to damagingly high levels of
endogenous ROS when PD risks are sufficiently large.
Conclusions: Our current results only consider one form of PD risk, however, we are sufficiently confident in them to conclude
that: (i) continuous long-term measurement of neurochemical dynamics provide a novel way to measure the temporal change
and system dynamics which determine Parkinsonian damage, and (ii) the bistable feedback switching predicted by mathematical
modelling seems to exist and that a deeper analysis of its characteristics would provide a way of understanding the pathogenic
mechanisms that initiate Parkinsonian cell damage.
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INTRODUCTION
Along with other neurodegenerative conditions,
Parkinson’s disease (PD) poses a growing threat to
our aging societies. The main risk factor for PD is
advanced age [1], while other issues such as exposure
ISSN 1877-7171/13/$27.50 © 2013 – IOS Press and the authors. All rights reserved
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to agricultural and industrial toxins, head trauma and
genetic predisposition also create an increased vulner-
ability. While the sources of risk are known, we do
not understand the detail of how PD risk factors cause
the initiation of self-sustaining Parkinsonian damage
within brains that leads to pathogenesis [2]. In particu-
lar, while there are qualitative descriptions of the devel-
opment of Parkinsonian damage as a ‘vicious cycle’ of
neurochemical interactions [3], there are nomathemat-
ical models for how the vicious cycle might work, and
no in vivo means of continuously monitoring the tem-
poral changes in neurochemicals involved in the cycle.
In recent years however, two developments (one the-
oretical and one experimental) have occurred which
address these limitations. In the theoretical devel-
opment, mathematical modelling has been used to
simulate and conduct theoretical analysis of neuro-
chemical bi-stability in cells under stress from PD risk
factors [4, 5]. Computational and theoretical analysis
of the models predicts that vulnerable neurons have a
switching property that (when under sufficiently severe
pressure from PD risk factors) causes them to irre-
versibly change to a Parkinsonian state. In particular,
mathematical modelling of interactions between reac-
tive oxygen species (ROS) and alphasynuclein (S)
predicts that the key functional mechanism in the
‘vicious cycle’ associated with Parkinsonian damage
is a bistable feedback switch that resembles known
biological motifs [6].
The experimental development is a sensing tech-
nology for continuously monitoring the real-time
variations of specific neurochemicals in the brains of
freely moving animals. Using Long Term In VivoElec-
trochemistry (LIVE) it is now possible tomeasure with
great specificity and sensitivity the relative concen-
trations of neurochemicals [7–9]. Animals fitted with
LIVE sensors can be used to study in real-time the tem-
poral changes in neurochemical levels that occur after
exposure to disease risk factors. For example, LIVEhas
been used to study neurochemical changes in an ani-
mal model of schizophrenia [10]. In the current article
we extend the use of LIVE to measure instantaneous
neurochemical changes in animals exposed to a partic-
ular form of PD risk factor, and use the experimental
results to assess theoretical predictions of a system-
atic neurochemical switching in the pathogenesis of
Parkinsonian damage within a cerebral compartment.
Theoretically, the compartment can consist of a region
within a neuron, a single neuron, a group of neurons
or an entire brain area. In the context of this paper,
the cerebral compartment is the region immediately
surrounding the LIVE sensors.
The mathematical and computational analysis of
how Parkinsonian damage occurs was intended to
reveal a generic principle of neurochemical switch-
ing. The aim of this article is to test this principle in
the specific case of animals exposed to a known PD
risk factor. We monitored the temporal variations in
nitric oxide (NO) within the brains of freely moving
rats under stress from paraquat (PQ) injections. We
then used temporal variations in NO levels to infer
the presence of switching in oxidative stress levels. To
capture the predicted switching process we made con-
tinuous measurements over a period of several days
using NO sensors implanted in the brains of freely
moving rats. Over the measurement period, animal
groups were subjected to either (i) single admin-
istrations of PQ of various levels, or (ii) repeated
administrations of a PQ dose of a fixed level. We
believe the results of these experiments are: (i) sup-
portive of a neurochemical switching mechanism in
the initiation of self-sustaining Parkinsonian damage,
and (ii) a demonstration of the value of LIVE for in
vivo neurochemical measurement of previously unob-
servable temporal changes during neurodegeneration.
MATERIALS AND METHODS
The use of a PQ animal model
Weused a toxin based animal model that was known
to us and that allowed PD risks to be introduced in
a quantitatively and temporally deterministic manner.
We selected the PQ animal model despite much debate
regarding the ability of PQ to cross the blood brain
barrier. Nonetheless, and because of its efficient redox
cycling, PQ is widely used in animal models of PD. In
particular, a strong correlation has been found between
the vulnerability to PD damage and the level of PQ
exposure [11–15]. For this reason, PQwasused to emu-
late the various levels of external toxic stress that form
the inputs to the aforementioned theoretical model.
The use of nitric oxide measurements as an
indicator of oxidative damage under PQ exposure
We have recently developed and extensively char-
acterised a Nafion®-modified Pt sensor capable of
real-time monitoring of brain extracellular NO in
multiple brain regions [7–9]. In particular we have
established a reliable method of directly measuring
endogenously generated NO in tissues with the neces-
sary sensitivity, spatial and temporal precision required
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for such a ubiquitous short-lived molecule. The tech-
nique requires the implantation of a Nafion®-modified
Pt sensor into a particular brain region, such that
(through application of a suitable potential profile) it is
possible tomeasure changes in concentration of NO on
a timescale from milliseconds to days. Until recently
the role ofNO in the pathophysiology of complex brain
disorders such as schizophrenia, Alzheimer’s disease
and PD has been hypothesized by indirect methods
of analysis. However, the Nafion®-modified Pt NO
sensor possesses the necessary characteristics and pre-
cision for specific applications in animal models of
disease [9], by providing direct, real-time, continuous
monitoring of neurochemical levels.
For example, a recent application of the NO sen-
sor in an animal model of schizophrenia has provided
the first explicit biochemical evidence for the involve-
ment of NO in the effects of the psychotomimetic drug
phencyclidine hydrochloride (PCP) [10]. To the best
of our knowledge the experiments described in this
paper are the first in which continuous chronic real-
time measurement of individual neurochemicals has
been applied in vivo to the study of neurodegenerative
conditions such as PD.
For our experimentswe used in vivomeasurement of
NO to infer corresponding changes in oxidative stress
levels. As a justification of this method, the literature
on oxidative damage reveals that NO is closely related
to oxidative damage in several ways. First, NO spon-
taneously reacts with another free radical, superoxide
(SO)under diffusion limiting conditions to formperox-
ynitrite (ONOO−); this is highly damaging to proteins
and cell membranes and must be neutralized by the
anti-oxidative pathways. During homeostasis SO is
rapidly removed by high concentrations of scaveng-
ing enzymes called superoxide dismutases (SOD)with
distinct isoenzymes located in the mitochondria, cyto-
plasm, and extracellular compartments [16, 17]. Under
exposure to PQ, the picture becomes more complex.
Firstly, PQ+ is re-oxidised back to PQ2+ by losing an
electron to O2, resulting in the formation of the latter’s
reduced form O2− or SO. PQ will also decouple the
neuronal (and also potentially, endothelial) NO syn-
thase (nNOS and eNOS) enzymes, thus reducing NO
synthesis and producing SO instead. Both these mech-
anisms would intuitively lead to a reduction in NO
concentration. However, PQ also elicits an inflamma-
tory response through theNF-κBpathway, which leads
to the expression of the inducible NO synthase (iNOS)
that would compensate for the lower NO levels or even
cause excess NO accumulation, which is also reported
for other PD inducing toxins [18–20].
The NO sensors were implanted in the ventral stria-
tum of a cohort of rats. After recovery from the surgery
the rats were placed in cages where they could move
freely and left until they exhibited normal behaviour.
They were then subjected to subcutaneous (in the back
of the subject) injections of various levels of PQ. The
high sensitivity and selectivity of theNOsensors [7–9],
in combination with continuous recording over several
days ensured that long-term dynamic changes of NO
in the rats were monitored in detail.
NO monitoring in the ventral striatum
Cell death in the substantia nigra (SN) and the asso-
ciated motor dysfunction is frequently used as the
defining characteristic of PD and on this basis the SN
would seem a preferred region for sensor implanta-
tion. However, our experimental objective is to detect
the initiation of Parkinsonian damage generally and
not the appearance of the defining symptom of PD.
Specifically, Braak’s staging model and post-mortem
evidence of widespread Parkinsonian damage in the
brains of people with PD [21, 22], show that Parkin-
sonian damage is not localised to the SN. As a result,
sensors can be implanted in any brain area feasibly
affected during staging and where measurements can
bemadewith a high level of confidence. In this context,
an extensive characterisation study of the NO sensor
performance has already been made with it implanted
in the ventral striatum [8]. This study provided the team
with a reliable and reproducible protocol for implan-
tation and validation of the sensor’s performance in
this brain area. Thus we measure NO in the ventral
striatum, on the basis that: (i) we can do this reliably
and reproducibly, and (ii) we are looking for the onset
of Parkinsonian damage in this area – not the defining
manifestation ofmotor dysfunction associatedwith SN
cell death.
Specificity of the sensed NO levels
The NO signal displayed in all figures is an average
level of extracellular NO measured around the mod-
ified sensor surface. This corresponds to interpreting
the mathematical model as representing an extracellu-
lar compartment containing the neurons in the region
of the ventral striatum covered by the sensors.
NO sensor preparation and surgical implantation
Themicrosensor is a Nafion®-modified Pt disk elec-
trode that has been extensively characterised both in
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vitro [9, 23] and in vivo [7, 8] and sold commercially
by BlueBox Sensors Ltd., Dublin, Ireland. NO sen-
sors were implanted following a previously described
procedure. Coordinates for the ventral striatum with
the skull levelled between bregma and lambda, were:
A/P+1.85,M/L± 1.3 from bregma andD/V – 6.8 from
dura respectively. A reference electrode (8T Ag wires,
200m bare diameter) was placed in the cortex and an
auxillary electrode (8T Ag wires, 200m bare diame-
ter) attached tooneof the support screws.The reference
potential provided by the bare Ag wire in brain tissue
is very similar to that of the saturated calomel elec-
trode (SCE) used in the in vitro characterization [24].
The electrodes and probe were fixed to the skull with
dental screws and dental acrylate (Associated Dental
Products, Swindon, UK). The rats were anesthetized
with the volatile anaesthesia Isoflurane, placed in a
Kopf stereotaxic instrument and kept on a heating pad
to prevent hypothermia. A 1mLkg−1 injection of the
opioid analgesic buprenorphine is administered sub-
cutaneously 10 minutes before the end of the surgery
and the animal allowed to rest. The animal is moni-
tored for the next few hours, before being transferred
to a holding bowl where it remains for the duration of
the experiment. The animal is allowed to recover for at
least 24 hours prior to connection to the potentiostat.
The desired potential (+900mV vs. Ag wire) is then
applied to the NO sensor and the current is allowed to
stabilise for approximately 4 – 5 days to allow for base-
line recordings. Following this period of stabilisation,
systemic administrations of PQ were commenced.
Mathematical model of NO response to PQ
The mathematical model predicting a systemic
switching of oxidative stress [4, 5] is a generic illus-
tration of ROS and S interactions under abstract
representations of all known PD risk factors. In
addition to the theoretically predicted switchingmech-
anism, the experimental responses to the PQ toxins
have additional characteristics which are specific to
this toxic risk. To help clarify the experimental inves-
tigation described here, the model in [5] was adapted
for reactions specifically associated with exposure to
PQ and for which there is significant supporting litera-
ture. The details of the adaptedmathematicalmodel are
described in from the Section 3 of the Supplementary
Material.
Chemicals and solutions
PQ (Methyl viologen dichloride hydrate) was pur-
chased from Sigma Chemical Co. (Dublin, Ireland).
A 0.9% solution of saline was prepared by dissolving
0.9 g NaCl in 100mL doubly distilled water. All sys-
temic administrations of PQweremade up in a solution
of 0.9% saline and administered subcutaneously in a
volume of 1mL.
Animals
Male Wistar rats (Charles River, U.K, 280–400 g)
were housed, with a maximum of four per cage in a
temperature (17–23◦C), humidity and light controlled
(12 h light, 12 h dark cycle) environment. Food and
water were available ad libitum. The animals were
allowed to acclimatise for at least one week prior to
surgery. All experimental procedures were performed
under license in accordance with the European Com-
munities Regulations 2002 (Irish Statutory Instrument
165/2013).
Experimental protocols
All experiments were carried out with each mem-
ber of the animal group in its home bowl. Implanted
electrodes were connected to the potentiostat through
a six-pin Teflon® socket and free movement of the ani-
mal was allowed via a Raturn® system (Bioanalytical
Systems, Inc, Indiana, USA).
Single injection of PQ
For low dose (5mgkg−1) PQ administrations, two
or four sensors were implanted bilaterally in the ven-
tral striatum of 6 Wistar rats (total sensor n= 12).
Following 4–5 days of baseline recording the animal
was subjected to a single 5mgkg−1 PQ injection and
NO levels were recorded for a period of 72 hours (3
hours pre injection baseline and 69 hours post injection
recording with time = 0 denoting time of injection).
For moderate dose (30mgkg−1) PQ administrations,
two or four sensors were implanted bilaterally in the
ventral striatum of 5 Wistar rats (total sensor n= 13).
Following 4–5 days of baseline recording the animal
was subjected to a single 30mgkg−1 PQ injection) and
NO levels were recorded for a period of 72 hours (3
hours pre injection baseline and 69 hours post injection
recording with time = 0 denoting time of injection).
Repeated injection of PQ
Significant responses in NO levels for single PQ
doses only appeared in the larger (30mgkg−1) dose.
For this reason we only performed experiments for
repetitive exposures on this higher PQ dose. The exper-
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iment was performed with an animal group of 4Wistar
rats (total sensor n= 11). Two or four sensors were
implanted bilaterally in the ventral striatum. Follow-
ing 4–5 days of baseline recording the animal was
subjected to the first 30mgkg−1 PQ injection and
NO levels were recorded for a period of 72 hours (3
hours pre injection baseline and 69 hours post injection
recording with time = 0 denoting time of injection).
After this 72 hour period the second 30mgkg−1 PQ
injection was administered and the NO levels recorded
for another 69 hours with time = 72 denoting time of
injection. The final 30mgkg−1 administrationwas per-
formed after this 138 hour recording period and the
NO levels were recorded for another 69 hours with
time = 141 denoting time of injection. Thus in the four
animal group NO levels were measured over 210 hour
period. In one case it was possible to administer a
fourth 30mgkg−1 injection after the 210 hour record-
ing period, and this animal was studied for a further
period. All injections were administered at 12 p.m.
on the particular day and at time = 0, 72, 141 hour
respectively. After termination of the experiments the
rats were decapitated and the brains were removed
and stored in 10% formaldehyde. The brains were
transferred to 30% sucrose solution and stored for
approximately 7 days at 4◦C. The sensor placement
was verified by sectioning the brains using a cryostat
and an atlas of the rat brain for reference [25].
Previouswork published by the group has illustrated
that there is no difference in NO levels recorded from
sensors implanted bilaterally in the ventral striatum,
supporting further the choice of implantation proto-
col [8].
Instrumentation and data presentation
Constant potential amperometry was performed
using previously describedmethods [7, 8].All data pre-
sented had baselines normalised to 100% illustrating
the overall change in current as a% of the pre-injection
baseline level. This removes both inter electrode and
inter animal variability by ensuring that the presented
NO changes are representative of the data from all the
animals used in each study. It is important to men-
tion that the total baseline current consists of basal
NO levels and a small contribution from the capaci-
tance current formed from the double layer that exists
between theNO sensor surface and the tissuematrix. In
most cases the capacitance current is negligible com-
pared to the faradaic response and can effectively be
ignored, however, it is necessary to consider this when
interpreting the results.
RESULTS
NO baseline measurement
Figure 1 summarises the results for the adminis-
tration of single doses of PQ. Figure 1A shows the
average baseline recording of NO levels in the ven-
tral striatum using the Nafion®-modified Pt sensor
over a 90 hour period in the absence of any injec-
tion. It is evident that there is little deviation from
the baseline level of 100% throughout the duration of
sampling in any of the recordings. The slight fluctu-
ations above and below basal levels are characteristic
of circadian rhythms associated with the animals and
validate previous assumptions made by other research
groups [26]. The stability and repeatability of the
baseline measurements confirm the suitability of the
amperometric sensors for long-term recordings of NO
levels in the living brain. Further validating plots are
given in the Supplementary Material (Supplementary
Figures 1 and 2).
Effect of single PQ injections
We considered the effect on brain NO of two lev-
els of dosage: 5mgkg−1 and 30mgkg−1 injections.
These two concentrations were used as they represent
a low and moderate dose of the toxin, and previous
work has illustrated that both low and moderate doses
have elicited contrasting behavioural affects in ani-
mals. In particular, Corasiniti et al. report behavioural
changes following systemic injections of 20mgkg−1
and 100mgkg−1 PQ, including tremors, salivation and
occasional wet dog shakes [27]. In the Corasiniti study,
a 5mgkg−1 dose of the toxin failed to produce gross
change in the subjects studied. Likewise, over the first
180 minutes our measurements of NO after 5mgkg−1
injection of the herbicide (Fig. 1B) showed no systemic
change. This contrasts with previous investigations
unrelated to the current PD study, but using theNOsen-
sor, which displayed a response to various treatments
and a return to baseline within this time frame [7–10].
To determine the long-term effect of PQ on NO levels,
a total measurement period of 72 hours was chosen (3
hours pre injection baseline and 69 hours post injection
recording with time = 0 denoting time of injection).
This period was deemed to be sufficient for any sys-
temic drug affect to be recorded and corresponds to
the time frames for change that were predicted in the
mathematical model of systemic switching to dam-
agingly high levels of endogenous ROS generation
[4, 5].
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Fig. 1. Baseline and responses to single PQ injections. (A) Average 3 hour time intervals of baseline data recorded from amperometric NO
sensors (n= 12) implanted in the ventral striatum of freely moving rats. Data represented as normalised current±S.E.M. (B) Average 3 hour
response following 5mgkg−1 injections of PQ (n= 9). Grey lines represent S.E.M. (C) Average of all NO responses to 30mgkg−1 injections
of PQ in freely moving animals (n= 13). 3 hours pre injection baseline and 69 hours post injection recording with time = 0 denoting time of
injection (D) Average of all NO responses to 5mgkg−1 injections of PQ in freely moving animals (n= 12). 3 hours pre injection baseline and
69 hours post injection recording with time = 0 denoting time of injection.
Effect of a single 5mgkg−1 injection of PQ
Figure 1D shows the average response from NO
sensors (n= 12) in an animal group over a 72 hour
period following exposure to 5mgkg−1 of PQ. There
are fluctuations above and below the baseline but the
overall trend is one ofminimal deviation frombaseline,
indicating that the animal’s regulatory mechanisms
are able to resist this level of toxic exposure. Hav-
ing said this, it is important to mention that there
were significant differences in the response of the 6
animals in this particular treatment group (see Sup-
plementary Figure 2). The sensors implanted in three
of the animals displayed transient decreases in current
over the period monitored in contrast to the increases
observed from the sensors implanted in the other three
animals. Our sensor manufacturing, testing and cali-
bration procedures are such that we are confident that
the measured differences between animals are not an
artefact of the sensor but are true reflections of dif-
ferences in the animal responses. In this context, we
believe the difference between responses reflects dif-
ferences in animal metabolism and the corresponding
different susceptibility to relatively low levels of toxic
exposure.
Effect of a single 30mgkg−1 injection of PQ
Figure 1C illustrates the effect of one 30mgkg−1
injection (n= 13) of PQ on NO levels in the brains of a
rat cohort (3 hours pre injection baseline and 69 hours
post injection recording with time = 0 denoting time of
injection). There is a clear trend in the NO response
observed over the 72 hours with a distinct decrease
in NO levels recorded. There was a more noticeable
change in the animal’s behaviour in comparison to the
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Fig. 2. The effect of multiple paraquat (30mg.kg−1) injections on NO monitored in the ventral striatum of freely moving rats. (A) Average
effect of first injection (0 hour, n= 11), (B) second injection (72 hour, n= 11), and (C) third injection (141 hour, n= 11). Data represented as
normalised current±S.E.M.
lower 5mgkg−1 dose including slight tremors and con-
tinual staring over the course of the recording. This is in
line with other groups who report similar behavioural
changes following administration of the toxin [28–31],
and confirm that there is a dose related effect of the
herbicide on NO levels. As described elsewhere, two
major phenomena are most probably involved here:
(i)-the decoupling of nNOS, switching to diaphorase
activity and production of SO instead of NO; and (ii)-
a delayed increase in SO, leading to a proportional
increase in the NO-SO reaction, thus removing NO.
eNOS is not explicitly considered here, but may play a
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role, even though its concentration is lower than nNOS
in the brain tissue.
Repeated exposure to 30mgkg−1 PQ injections
Figure 2 shows the effect of repeated injections of
30mgkg−1 PQ on the NO levels recorded using the
amperometric sensors (n= 11). These are shown as
snapshots of three time intervals during the 210 hour
experiment described in Experimental Protocols. Fig-
ure 2A covers the first 72 hours after the first injection
at time = 0; Fig. 2B is a second 72 hour period after
the second injection at time 72 hours; and Fig. 2C
is a third 72 hour period after the third injection at
time 141 hours. In all figures there is an averaged pre-
injection baseline period of 3 hours included; this is
used to give the relative 100% level for each particular
figure.
Figure 2A illustrates the effect of an initial expo-
sure to the toxin over a 72 hour period. As previously
observed for the single 30mgkg−1 injection, there
is a systematic decrease in NO levels recorded over
this period. Figure 2B shows the effect of the sec-
ond 30mg/kg−1 injection at time = 72 hours. In this
time interval, the decrease in NO relents and the NO
levels remain close to baseline throughout the initial
50 hours following injection, after which a delayed
increase is observed from baseline. This suggests that
the second toxic exposure causes a secondary mecha-
nism of action to take control and initiate an increase in
NO levels. It is our understanding that this increase in
NO levels may occur via a glutamatergic pathway and
evidence exists supporting a mechanism by which PQ
induces glutamate efflux [11, 12]. However, a defini-
tive pathway has yet to be elucidated. It is well known
that excitotoxicity is a process induced byN-methyl-D-
aspartate (NMDA) receptor activation through an NO
mediated process. For example, Dugan and Choi have
reported that excessive NMDA receptor activation is
a central mechanism of neurodegeneration in several
neurological diseases [32].
Figure 2C shows that, following a third exposure to
30mgkg−1, a clear increase in NO levels occurs over
the subsequent 69-hour recording period for animals
in the group. This experimental finding supports the
theory that above a certain threshold of PQ exposure
the diaphorase activity of NOS is superseded by toxin
induced increase in glutamate efflux. Excessive activa-
tion of the NMDA receptor results in Ca2+ influx into
the cell that is a prerequisite (along with the protein
calmodulin) for the production of neuronal NO. How-
ever, it is important to emphasise that PQ also elicits
an inflammatory response through theNF-κBpathway,
which leads to the expression of the inducible NO syn-
thase (iNOS) and to further NO production [18–20].
The NO then diffuses out from the cell into the extra-
cellular space where it is detected by the amperometric
sensor. Whatever the mechanism at work, it is clear
that repetitive injections of the toxin alter production
of NO. It is hypothesised that the increased NO pro-
duced diffuses across to dopaminergic terminals where
it carries out a role in excitotoxicity, probably through
its high affinity for the SO radical, resulting in the for-
mation of the highly toxic anion ONOO− which is the
key culprit of nitric oxidemediated toxicity.ONOO− is
a lipid-permeable ion that has a wider range of chemi-
cal targets thanNO. It can oxidise proteins, lipids, RNA
and DNA. It inhibits enzyme function in the mitochon-
drial respiratory chain and decreases ATP synthesis
resulting in a weakened energy metabolism of neurons
[12].
Figure 2 provides us with a set of ‘snapshots’ of the
effect of the three successive injections on the animal
group over three successive time intervals. Each snap-
shot shows a different phase in the NO response as
PQ injections are repeated, and illustrate the different
neurochemical reactions that come into play at each
stage, with the predicted shift to a consistently high
level of NO occurring in the last stage after injection
3 (Fig. 2C). For completeness, a plot of the variations
in NO over the entire experimental period is given in
Fig 3. This plot of NO variation over the entire time
period clearly shows that there is a systematic move to
an elevated level of NO associated with the third injec-
tion (injection times are indicated by arrows).After this
point the NO for all animals in the group increased
in a characteristic manner to a high level of NO and
stabilised at that value. The experimentally observed
switching in NO levels in Fig. 3 should be compared
with the simulations of the theoretically predicted bi-
stable switchingmechanism in [4, 5] and characterised
by the feedback motif in [4].
The group experiment with 30mgkg−1 was ter-
minated after 210 hours. However, we were able to
monitor one unusually resilient member of the group
over a longer period (13 days) that included a fourth
30mgkg−1 injection. It is unusual to obtain continu-
ous neurochemical measurements for a subject over
such a long period after sustained toxin insults. For
this reason, the single animal results are included in
the Supplementary Material, together with a mathe-
matical model and simulations that relate specifically
to the response characteristics displayed by this single
subject.
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Fig. 3. Showing the variations in NO over the entire experimental period for an animal group exposed to three successive 30mgkg−1 injections
of PQ at 72 hour periods. The experiment was terminated before the fourth injection.
DISCUSSION
Systematic changes in NO levels after a single
30mgkg−1 PQ injection
With reference to Figs. 1C and 2A, we associate
the initial dip in the sensed NO as an indicator of
diaphorase action triggered by PQ. In this context,
a number of recent publications have considered the
importance of diaphorase activity in PQ-mediated tox-
icity [31, 33]. Cellular diaphorases are a class of
enzymes that transfer electrons from NADPH to small
molecules such as PQ [12, 34, 35]. Evidence suggests
that NOS can act as a PQdiaphorase that causes uncou-
pling of the enzyme at the reductase domain, resulting
in the generation of SO and depleting NO. Our find-
ings with single 30mgkg−1 injections of PQ support
this diaphorase hypothesis. It is noteworthy that in all
animals a 30mgkg−1 injection produced a sustained
decrease in NO levels in comparison to the apparent
lack of response to a 5mgkg−1 injection. It is possi-
ble that at higher concentrations of PQ greater electron
transfer occurs between the toxin and NADPH and this
causes increased uncoupling of NOS and an overall
increase in SO and decrease in NO. The NO current
fails to recover back to pre-injection levels following
the higher dose due to the efficient redox cycling of
PQ that results in continuous uncoupling of NOS and
inhibition of NO production.
Systematic changes in NO levels after repeated
30mgkg−1 PQ injections
The systematic changes shown in the animal groups
(Figs. 2 and 3) after injection three provide supporting
evidence of a predicted bistability-induced switching
in neurochemical state within the rat brains. The bi-
stability is one where excessive risk exposure causes
endogenous oxidative stress to switch from a healthy
homeostatic level to a damagingly high level of oxida-
tive stress. The mathematical models in [4, 5] predict
a switch like transition to damagingly high levels of
ROS, and the animal group result in Fig. 2C (and for
the entire time period in Fig. 3) is coherent with this
prediction. Subsequent to the systemic switching fur-
ther behaviours are to be expected that are associated
with the severity and the type of the risk – we present
models and simulations of the possible nature of these
in the Supplementary Material.
CONCLUSIONS
Real-time measurements of NO in the ventral stria-
tum of freely moving rats show the effect of PQ and its
link to theoretically predicted changes in ROS. In par-
ticular the observation of a characteristic change in NO
levels supports the theoretical prediction of a bistable
neurochemical switching mechanism for exposure to
PD risk factors above a certainmagnitude. In the partic-
ular case of PQ injections, in vivoNOmeasurements in
rats exhibit a switching phenomenon for repeated toxic
insults of 30mgkg−1 while low levels (5mgkg−1) do
not. There was variability between the responses of
the animals used in the experimental groups, but we
believe that this is indicative of intrinsic differences in
susceptibility between animals in the group. The obser-
vation that permanent PD damage was initiated by
repeated toxic insults, and that there were differences
in susceptibility of the subjects may have relevance
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Fig. 4. Proposed mechanism for PQ induced toxicity (1) Diaphorase activity displayed by NOS in the presence of PQ. NOS transfer electrons
from NADPH to PQ causing inhibition of complex I of the mitochondrial respiration chain (ETC) resulting in deficient ATP synthesis and
neuronal vulnerability. PQ·+ undergoes reoxidation in the presence of O2 generating O2·− (SO) (2) Following repeated exposure PQ·+ induces
excessive glutamate release that results in hyperactivation of NMDA receptors causing an increase in NO production. An alternative source of
increasing NO levels occurs via increased iNOS expression (3) Excess levels of NO react with O2·− resulting in the formation of toxic ONOO−,
NO also has a role in mediating DA release and oxidation through the action of its metabolite NO2− (4) ONOO− produced following the
spontaneous reaction of NO and O2·− directly oxidises DA or indirectly via decomposition to NO2− (5) Oxidation of proteins, lipids, & DNA
by ROS (OH· & ONOO−) and disruption to homeostatic degradation of mis-folded proteins (6) -S mis-folding & aggregation in dopaminergic
neurons prevents DA storage in vesicles resulting in increased DA oxidation, -S mis-folding & aggregation make up Lewy Bodies (7) DA not
stored in vesicles undergoes oxidation by a number of mechanisms resulting in the further generation of ROS (O2·− & H2O2) and DA quinone
which all feedback into eventual -S mis-folding & aggregation.
in the debate concerning human exposure to certain
agricultural and industrial chemicals.
We believe that the NO measurements described
here support an important theoretical prediction con-
cerning how self-sustaining Parkinsonian damages
starts. Specifically the data provides experimental
evidence of a bistable neurochemical switch that is
activated by stresses from PD risk factors. The mathe-
matical models that motivated our experiments were
for a generalised situation and required changes to
describe the specific risk presented by PQ. This point
suggests that although each PD risk factor or com-
bination of risk factors, maybe different, the core
mechanism that initiates the disease state can be
described by the unifying phenomenon of a bistable
neurochemical system that causes a switch to elevated
ROS levels. A further unifying observation is that all
risk factors acting on the neurochemical switch medi-
ate the neuronal ATP availability – supporting the role
for neuronal energy deficits as a unifying feature of
known PD risk factors [36–38].
A caveat is that the system that characterises the
NO response to PQ (Fig. 4) is more complex than
the generic mathematical model used to motivate our
experiments [4]. Such differences are to be expected,
as the original model was developed as a generic feed-
backmotif that is prototypical of the transition between
healthy and disease states. To answer this pointwe have
included in the Supplementary Material a model that
includes PQ specific reactions and captures the specific
NO dynamics observed during the in vivo measure-
ments for an individual animal’s responses.
Other potentially useful findings for PD research
include (i) the importance of both the size and timing of
toxic exposure, (ii) the variations between responses to
individual external stresses and, (iii) that the develop-
ment of damaging levels of oxidative species seems to
be intrinsically dynamic. This last point is relevant for
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experiments based upon point measurements at one
specific time – usually the end point. Such observa-
tions will potentially show widely differing results,
not because of genuine experimental differences, but
because the measurement points occur at different
phases during dynamic changes in neurochemical
levels.
Beyond the specific results concerning PD, the
experiments shown here demonstrate the value of
LIVE for continuous long-term sensing of neurochem-
ical concentrations as a tool for neurodegenerative
disease research in general. For example, the temporal
variations revealed in Figs. 2 and 3, would have been
extremely difficult, if not impossible, to detect using
any other sensing technology. The long-term varia-
tions in neurochemical levels illustrate the importance
of continuous measurements as a tool for obtaining
a global and comprehensive picture of change during
neurodegeneration. In summary, the findings from this
body of work lend support to the suitability of such
sensors as an important tool in monitoring the mani-
festation of neurodegenerative diseasewhere oxidative
stress is a central feature. It would be of great interest
to combine various other microsensors for real-time
quantification of several important markers in PD.
The BioAnalytics Laboratory at NUI Maynooth has
a pipeline of such sensors that allow continuous real-
time detection of markers such as glutamate, hydrogen
peroxide and ascorbic acid. Collectively these sensors
would allow unprecedented recordings in pre-clinical
models of PD and illustrate for the first time the man-
ifestation of this debilitating disease.
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